gabapentin has been researched along with Conjugate Nystagmus in 22 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective examiner-blind, cross-over study was conducted to compare the efficacy of memantine (40 or 60 mg/day) and gabapentin (1,200 mg/day) as therapy for acquired fixational pendular nystagmus (APN) in 11 patients with multiple sclerosis." | 9.14 | Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin. ( Albrecht, H; Dieterich, M; Pöllmann, W; Starck, M; Straube, A, 2010) |
| "The aim of this study was to report relief of optokinetic-triggered vertigo (OKTV) with low-dose gabapentin in three patients with periodic vestibulocerebellar ataxia [episodic ataxia type 4 (EA4); OMIM 606552]." | 8.02 | Gabapentin Relieves Vertigo of Periodic Vestibulocerebellar Ataxia: 3 Cases and Possible Mechanism. ( Coin, JT; Vance, JM, 2021) |
| "The authors retrospectively analysed Snellen visual acuity (VA), subjective visual function, and eye movement recordings of 23 patients with nystagmus (13 secondary to multiple sclerosis, three associated with other neurological diseases, two idiopathic infantile, and five with associated ocular diseases) treated with gabapentin or memantine." | 7.73 | The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study. ( Gottlob, I; McLean, RJ; Proudlock, FA; Sarvananthan, N; Shery, T, 2006) |
| "A prospective examiner-blind, cross-over study was conducted to compare the efficacy of memantine (40 or 60 mg/day) and gabapentin (1,200 mg/day) as therapy for acquired fixational pendular nystagmus (APN) in 11 patients with multiple sclerosis." | 5.14 | Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin. ( Albrecht, H; Dieterich, M; Pöllmann, W; Starck, M; Straube, A, 2010) |
| "The aim of this study was to report relief of optokinetic-triggered vertigo (OKTV) with low-dose gabapentin in three patients with periodic vestibulocerebellar ataxia [episodic ataxia type 4 (EA4); OMIM 606552]." | 4.02 | Gabapentin Relieves Vertigo of Periodic Vestibulocerebellar Ataxia: 3 Cases and Possible Mechanism. ( Coin, JT; Vance, JM, 2021) |
| "The authors retrospectively analysed Snellen visual acuity (VA), subjective visual function, and eye movement recordings of 23 patients with nystagmus (13 secondary to multiple sclerosis, three associated with other neurological diseases, two idiopathic infantile, and five with associated ocular diseases) treated with gabapentin or memantine." | 3.73 | The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study. ( Gottlob, I; McLean, RJ; Proudlock, FA; Sarvananthan, N; Shery, T, 2006) |
| "A 40-year-old patient with acquired horizontal and vertical nystagmus and severe oscillopsia secondary to multiple sclerosis had combined treatment with gabapentin and a vertical Kestenbaum-type procedure." | 3.71 | Combined pharmacologic and surgical approach to acquired nystagmus due to multiple sclerosis. ( Constantinescu, CS; Gottlob, I; Jain, S; Proudlock, F, 2002) |
| "The most common causes of acquired pendular nystagmus (APN) are multiple sclerosis (MS) and oculopalatal tremor (OPT), both of which result in poor visual quality of life." | 2.94 | Gabapentin and Memantine for Treatment of Acquired Pendular Nystagmus: Effects on Visual Outcomes. ( Abouaf, L; Berthiller, J; Colombet, B; Nerrant, E; Pollet-Villard, F; Tilikete, C; Vie, AL; Vighetto, A; Vukusic, S, 2020) |
| "Acquired brain injury can cause eye movement disorders which may include: strabismus, gaze deficits and nystagmus, causing visual symptoms of double, blurred or 'juddery' vision and reading difficulties." | 2.58 | Interventions for eye movement disorders due to acquired brain injury. ( Dodridge, CS; Evans, JR; Garcia-Finana, M; Hanna, K; Howard, C; Jarvis, KA; Maan, T; MacDiarmid, SL; Noonan, CP; North, L; Rodgers, H; Rowe, FJ, 2018) |
| "Acquired pendular nystagmus may respond to gabapentin or memantine; downbeat and upbeat nystagmus to aminopyridines; and periodic alternating nystagmus to baclofen." | 2.48 | The pharmacological treatment of acquired nystagmus. ( Kennard, C; Mehta, AR, 2012) |
| "BACKGROUND Acquired pendular nystagmus (APN) is a back and forth, oscillatory eye movement in which the 2 oppositely directed slow phases have similar waveforms." | 1.72 | Pharmacological and Behavioral Strategies to Improve Vision in Acquired Pendular Nystagmus. ( Abegg, M; Brügger, D; Kerkeni, H; Mantokoudis, G; Zee, DS, 2022) |
| "Treatment with gabapentin was initiated for OPT presumed secondary to neuro-Behçet disease." | 1.42 | Neuro-Behçet disease presenting with oculopalatal tremor. ( Espino Barros Palau, A; Foroozan, R; Lee, AG; Morgan, ML, 2015) |
| "Ocular oscillations, with features of pendular nystagmus, appeared early during training of both horizontal and vertical pursuit in all four monkeys." | 1.37 | Oscillatory eye movements resembling pendular nystagmus in normal juvenile macaques. ( Akao, T; Barnes, G; Belton, T; Fukushima, J; Fukushima, K; Kase, M; Kurkin, S; Leigh, RJ; Shichinohe, N, 2011) |
| "Acquired pendular nystagmus (APN) occurs with multiple sclerosis (MS) and oculopalatal tremor (OPT); distinct features of the nystagmus have led to the development of separate models for their pathogenesis." | 1.37 | Pharmacological tests of hypotheses for acquired pendular nystagmus. ( Leigh, RJ; Optican, LM; Shaikh, AG; Thurtell, MJ, 2011) |
| "Acquired Pendular Nystagmus (APN) may cause distressing visual symptoms in patients who are already suffering a severe general disease." | 1.31 | Improvement of acquired pendular nystagmus by gabapentin: case report. ( Fabre, K; Smet-Dieleman, H; Zeyen, T, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 3 (13.64) | 2.80 |
| Authors | Studies |
|---|---|
| Kerkeni, H | 1 |
| Brügger, D | 1 |
| Mantokoudis, G | 1 |
| Abegg, M | 1 |
| Zee, DS | 1 |
| Coin, JT | 1 |
| Vance, JM | 1 |
| Rowe, FJ | 1 |
| Hanna, K | 1 |
| Evans, JR | 1 |
| Noonan, CP | 1 |
| Garcia-Finana, M | 1 |
| Dodridge, CS | 1 |
| Howard, C | 1 |
| Jarvis, KA | 1 |
| MacDiarmid, SL | 1 |
| Maan, T | 1 |
| North, L | 1 |
| Rodgers, H | 1 |
| Nerrant, E | 1 |
| Abouaf, L | 1 |
| Pollet-Villard, F | 1 |
| Vie, AL | 1 |
| Vukusic, S | 1 |
| Berthiller, J | 1 |
| Colombet, B | 1 |
| Vighetto, A | 1 |
| Tilikete, C | 1 |
| Morgan, ML | 1 |
| Espino Barros Palau, A | 1 |
| Lee, AG | 1 |
| Foroozan, R | 1 |
| Kalla, R | 1 |
| Spiegel, R | 1 |
| Wagner, J | 1 |
| Rettinger, N | 1 |
| Jahn, K | 1 |
| Strupp, M | 1 |
| Nebbioso, M | 1 |
| D'Innocenzo, D | 1 |
| Rapone, S | 1 |
| Di Benedetto, G | 1 |
| Grenga, R | 1 |
| McLean, RJ | 2 |
| Gottlob, I | 5 |
| Starck, M | 1 |
| Albrecht, H | 1 |
| Pöllmann, W | 1 |
| Dieterich, M | 1 |
| Straube, A | 2 |
| Thurtell, MJ | 2 |
| Joshi, AC | 1 |
| Leone, AC | 1 |
| Tomsak, RL | 1 |
| Kosmorsky, GS | 1 |
| Stahl, JS | 2 |
| Leigh, RJ | 5 |
| Pieh-Beisse, C | 1 |
| Lagrèze, WA | 1 |
| Shichinohe, N | 1 |
| Barnes, G | 1 |
| Akao, T | 1 |
| Kurkin, S | 1 |
| Fukushima, J | 1 |
| Kase, M | 1 |
| Belton, T | 1 |
| Fukushima, K | 1 |
| Shaikh, AG | 1 |
| Optican, LM | 1 |
| Mehta, AR | 1 |
| Kennard, C | 1 |
| Jain, S | 1 |
| Proudlock, F | 2 |
| Constantinescu, CS | 1 |
| Fabre, K | 1 |
| Smet-Dieleman, H | 1 |
| Zeyen, T | 1 |
| Rahman, W | 1 |
| Shery, T | 1 |
| Proudlock, FA | 1 |
| Sarvananthan, N | 2 |
| Choudhuri, I | 1 |
| Averbuch-Heller, L | 2 |
| Tusa, RJ | 1 |
| Fuhry, L | 1 |
| Rottach, KG | 2 |
| Ganser, GL | 1 |
| Heide, W | 1 |
| Büttner, U | 1 |
| von Maydell, RD | 1 |
| Collins, SD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Examining the Effect of Eye Gaze Technology on Children With Cortical Visual Impairment and Its Impact on Occupational Performance[NCT06067607] | 10 participants (Anticipated) | Interventional | 2023-02-01 | Recruiting | |||
| Comparison of Oral Gabapentin and Pregabalin in Postoperative Pain Control After Photorefractive Keratectomy: a Prospective, Randomized Study.[NCT00954187] | 8 participants (Actual) | Interventional | 2009-11-30 | Terminated (stopped due to PI left institution) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for gabapentin and Conjugate Nystagmus
| Article | Year |
|---|---|
Interventions for eye movement disorders due to acquired brain injury.
Topics: 4-Aminopyridine; Abducens Nerve Diseases; Amifampridine; Amines; Baclofen; Botulinum Toxins; Brain I | 2018 |
[Pharmacotherapy of central oculomotor disorders].
Topics: 4-Aminopyridine; Amifampridine; Amines; Baclofen; Cyclohexanecarboxylic Acids; Diagnosis, Differenti | 2008 |
[Nystagmus in ophthalmology].
Topics: Amines; Baclofen; Cyclohexanecarboxylic Acids; Diagnostic Techniques, Ophthalmological; Eye Diseases | 2009 |
The pharmacological treatment of nystagmus: a review.
Topics: Amines; Animals; Baclofen; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; | 2009 |
The pharmacological treatment of acquired nystagmus.
Topics: Amines; Aminopyridines; Baclofen; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; | 2012 |
Pharmacology of vertigo/nystagmus/oscillopsia.
Topics: Amines; Benzodiazepines; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; GABA Agonis | 2005 |
4 trials available for gabapentin and Conjugate Nystagmus
| Article | Year |
|---|---|
Gabapentin and Memantine for Treatment of Acquired Pendular Nystagmus: Effects on Visual Outcomes.
Topics: Adult; Cross-Over Studies; Excitatory Amino Acid Antagonists; Eye Movements; Female; Gabapentin; Hum | 2020 |
Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin.
Topics: Adult; Amines; Brain Stem; Clinical Protocols; Cross-Over Studies; Cyclohexanecarboxylic Acids; Dose | 2010 |
Crossover trial of gabapentin and memantine as treatment for acquired nystagmus.
Topics: Adult; Amines; Cross-Over Studies; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; E | 2010 |
A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus.
Topics: Acetates; Adult; Aged; Amines; Anticonvulsants; Baclofen; Cyclohexanecarboxylic Acids; Double-Blind | 1997 |
12 other studies available for gabapentin and Conjugate Nystagmus
| Article | Year |
|---|---|
Pharmacological and Behavioral Strategies to Improve Vision in Acquired Pendular Nystagmus.
Topics: Eye Movements; Female; Gabapentin; Humans; Memantine; Middle Aged; Nystagmus, Pathologic; Vision Dis | 2022 |
Gabapentin Relieves Vertigo of Periodic Vestibulocerebellar Ataxia: 3 Cases and Possible Mechanism.
Topics: Ataxia; Gabapentin; Humans; Nystagmus, Pathologic; Vertigo | 2021 |
Neuro-Behçet disease presenting with oculopalatal tremor.
Topics: Adult; Amines; Anticonvulsants; Behcet Syndrome; Cyclohexanecarboxylic Acids; Female; Gabapentin; ga | 2015 |
[Pharmacological treatment of nystagmus].
Topics: 4-Aminopyridine; Amines; Anticonvulsants; Baclofen; Cyclohexanecarboxylic Acids; Dopamine Agents; Ga | 2011 |
Oscillatory eye movements resembling pendular nystagmus in normal juvenile macaques.
Topics: Amines; Animals; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Gabapentin; gamma-A | 2011 |
Pharmacological tests of hypotheses for acquired pendular nystagmus.
Topics: Amines; Baclofen; Cerebellar Cortex; Cyclohexanecarboxylic Acids; Eye Movements; Gabapentin; gamma-A | 2011 |
Combined pharmacologic and surgical approach to acquired nystagmus due to multiple sclerosis.
Topics: Acetates; Adult; Amines; Combined Modality Therapy; Cyclohexanecarboxylic Acids; Diplopia; Excitator | 2002 |
Improvement of acquired pendular nystagmus by gabapentin: case report.
Topics: Acetates; Administration, Oral; Amines; Baclofen; Cyclohexanecarboxylic Acids; Female; Gabapentin; g | 2001 |
Oral gabapentin treatment for symptomatic Heimann-Bielschowsky phenomenon.
Topics: Administration, Oral; Amines; Cyclohexanecarboxylic Acids; Electronystagmography; Excitatory Amino A | 2006 |
The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study.
Topics: Adolescent; Adult; Aged; Amines; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Gab | 2006 |
Survey of management of acquired nystagmus in the United Kingdom.
Topics: Amines; Baclofen; Cyclohexanecarboxylic Acids; Drug Utilization; Excitatory Amino Acid Antagonists; | 2007 |
A pilot study of gabapentin as treatment for acquired nystagmus.
Topics: Acetates; Adult; Amines; Anticonvulsants; Brain Stem; Cerebrovascular Disorders; Cyclohexanecarboxyl | 1996 |